SOURCES SOUGHT
66 -- RECOVERY - Varian RapidArc upgrade for existing Varian Clinac 21-EX instrument
- Notice Date
- 2/25/2010
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- SS-100039-2010-NG
- Archive Date
- 3/23/2010
- Point of Contact
- Malinda L Holdcraft, Phone: (301) 402-4509, Caren N Rasmussen, Phone: (301) 402-4509
- E-Mail Address
-
holdcram@exchange.nih.gov, cr214i@nih.gov
(holdcram@exchange.nih.gov, cr214i@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- RECOVERY SOURCES SOUGHT NOTICE: RECOVERY - Varian RapidArc upgrade for existing Varian Clinac 21-EX instrument. Notice Number: SS-100039-2010-NG Issued By: National Cancer Institute (NCI), (http://www.nci.nih.gov) Office of Acquisitions (OA) Key Dates: Capability Statement Due Date: March 8, 2010 General Information: RECOVERY: This Sources Sought Notice (SS) is for information and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of the National Cancer Institute (NCI). Purpose: The purpose of this Sources Sought Notice is to identify qualified small business concerns including 8(a), HUBZone or Service-Disabled Veteran-owned business concerns that are interested in and capable of performing the work described herein. The NCI does not intend to award a contract on the basis of responses received nor otherwise pay for the preparation of any information submitted. As a result of this Sources Sought Notice, the NCI may issue a Request for Quotation (RFQ). THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. However, should such a requirement materialize, no basis for claims against NCI shall arise as a result of a response to this Sources Sought Notice or the NCI's use of such information as either part of our evaluation process or in developing specifications for any subsequent requirement. Description of Information to be included in the Capability Statement: The following characteristics apply: Upgrades must be an existing FDA approved medical device. RapidArc Upgrade for the existing Varian Clinac 21 EX to include • A single linear accelerator to provide the capability to simultaneously modulate aperture shape, dose rate and gantry speed continuously through 360 degrees of gantry rotation during an arc beam delivery; • Shall be capable of generating IMRT - quality does distributions in a single, optimized arc around the patient - in two minutes or less; and • Clinac beam shall be continuous and smooth for dose rates. Eclipse RapidArc Planning License Upgrade: • Shall support the dynamic arc treatments produced through volumetric dose optimization; • Shall provide dynamic MLC, variable does rate and variable gantry speed; • Shall support coplanar and non-coplanar arcs; • Shall support full arcs, partial arcs, and avoidance sectors; and • Shall be Eclipse dose dynamic arc software - conformal arc for dMLC. Eclipse Hardware Refresh - Calculation Workstation • Dual quad processor calculation - eclipse NAICS Code and Size Standard: In the event an RFQ is issued, North American Industry Classification System (NAICS) code 334516 with a size standard of 500 employees is being considered. How to Submit a Response: Page Limitations: Interested qualified small business organizations should submit a tailored capability statement for this requirement not to exceed 10 single sided pages including all attachments, resumes, charts, etc. (single space, 12 point font minimum) that clearly details the ability to perform the aspects of the notice described above. All proprietary information should be marked as such. Statements should also include an indication of current certified small business status; this indication should be clearly marked on the first page of your capability statement (preferable placed under the eligible small business concern's name and address). Responses will be reviewed only by NCI personnel and will be held in a confidential manner. Due Date: Capability statements are due no later than 11a.m. March 8, 2010. Number of Copies and Delivery Point: Please submit one (1) original and three (3) copies of your response as follows: If hand-delivered or sent by mail delivery: National Cancer Institute - Office of Acquisition Malinda Holdcraft - Contact Specialist 6120 Executive Boulevard, Room 6072 Rockville, MD 20852-7194 All capability statements sent in response to the Sources Sought Notice must be submitted in writing to Malinda Holdcraft. All responses must be received at NCI by the specified due date and time in order to be considered. No faxed or electronic mail submissions will be accepted. Point of Contact: Inquiries concerning this Notice may be direct to: Malinda Holdcraft Contract Specialist 6120 Executive Boulevard, Room 6072 Rockville, MD 20852-7194 holdcram@exchange.nih.gov
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/SS-100039-2010-NG/listing.html)
- Record
- SN02076657-W 20100227/100226094815-6cf691a9d0255ca570be46dfe04979cc (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |